Skip to main content

Table 3 Factors (non-measurable variables) which significantly influence NT-proBNP level.

From: Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study

Factors which significantly affect NT-proBNP

after inclusion

after 2 months

atorvastatin treatment

-

p = 0.01

renal insufficiency

-

p = 0.04

atrial fibrillation

p = 0.03

-

digoxin therapy

p = 0.001

p = 0.001

  1. ABBREVIATIONS: NT-proBNP - N-terminal pro-brain natriuretic peptide.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X